Rua Bioscience Says Sales For Q1 FY26 Are A Record
RefinitivMeno di 1 minuto di lettura
Rua Bioscience RUA:
SALES FOR Q1 FY26 ARE A RECORD
RENOUCENABLE RIGHTS ISSUE OF 1 NEW SHARES FOR EVERY 3 EXISTING SHARES TO RAISE UP TO NZ$2MILLION
ISSUE PRICE UNDER RIGHTS OFFER NZ$0.025 PER SHARE
Accedi o crea un account gratuito per leggere queste notizie